A biobehavioral perspective on depressive symptoms in patients with cerebral astrocytoma

Journal of Neuroscience Nursing

Volumn 43, Issue 1, 2011, Pages 17-28

  Starkweather, Angela R ^a   Sherwood, Paula ^b   Lyon, Debra E ^a   McCain, Nancy L ^a   Bovbjerg, Dana H ^c,d   Broaddus, William C ^e  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c Biobehavioral Medicine in Oncology Program   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASTROCYTOMA; BRAIN TUMOR; DEPRESSION; HUMAN; METHODOLOGY; NURSING; ONCOLOGY NURSING; PSYCHOLOGICAL ASPECT; RISK FACTOR;

ASTROCYTOMA; BRAIN NEOPLASMS; DEPRESSION; HUMANS; ONCOLOGIC NURSING; RISK FACTORS;

EID: 78651513513     PISSN: 08880395     EISSN: None     Source Type: Journal    
DOI: 10.1097/JNN.0b013e3182029859     Document Type: Article

References (65)

1. American Cancer Society. (2007). Cancer facts and figures, 2007. Atlanta: Author. Retrieved August 30, 2007, from http://www.cancer.org/downloads/STT/ CAFF2007PW Secured.pdf
2. Anisman, H., & Merali, Z. (2003). Cytokines, stress and depressive illness: Brain-immune interactions. Annals of Medicine, 35, 2-11.
3. Appleby, B. S., Appleby, K. K., & Rabin, P. V. (2008). Predictors of depression and anxiety in patient with intracranial neoplasms. Journal of Neuropsychiatry and Clinical Neurosciences, 20, 447-449.
4. Armstrong, C. L., Goldstein, B., Cohen, B., Jo, M. Y., & Tallent, E. M. (2002). Clinical predictors of depression in patients with low-grade brain tumours: Consideration of a neurological versus a psychogenic model. Journal of Clinical Psychology in Medical Settings, 9, 97-107.
5. Arnold, S. D., Forman, L. M., Brigidi, B. D., Carter, K. E., Schweitzer, H. A., Quinn, H. E., et al. (2008). Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. Neuro-Oncology, 10, 171-181.
6. Bondy, M. L., Scheurer, M. E., Malmer, B., Barnholtz Sloan, J. S., Davis, F. G., & Il'yasova, D. (2008). Brain tumor epidemiology: Consensus from the brain tumor epidemiology consortium. Cancer, 113, 1953-1968.
7. Brommeland, T., Rosengran, L., Fridland, S., Hennig, R., & Isaksen, V. (2007). Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas. Acta Neurologica Scandinavica, 116, 380-384.
8. Brown, P. D., Ballman, K. V., Rummans, T. A., Maurer, M. J., Sloan, J. A., Boeve, B. F., et al. (2006). Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. Journal of Neuro-oncology, 76, 283-291.
9. Brown, P. D., Maurer, M. J., Rummans, T. A., Pollock, B. E., Ballman, K. V., Sloan, J. A., et al. (2005). A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: The impact of the extent of resection on quality of life and survival. Neurosurgery, 57, 495-504.
10. Central Brain Tumor Registry of the United States. (2008). Primary brain tumors in the United States: Statistical report 2005-2007 years data collected. Hinsdale, IL: Author.
11. Chen, T. C., Wasten, P., Su, S., Rawlinson, N., Hofman, F. M., Hill, C, K., et al. (2002). The type IV phosphodiesterase inhibitor rolipram induces expression of the cell cycle inhibitors p21 (Cip 1) and p27 (Kip 1), resulting in growth inhibition, increased differentiation, and subsequent apoptosis of malignant A-172 glioma cells. Cancer Biology and Therapy, 1, 268-276.
12. Claus, E. B., & Black, P. M. (2006). Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: Data from SEER program, 1973-2001. Cancer, 15, 1358-1363.
13. D'Angelo, C., Mirijello, A., Leggio, L., Ferrulli, A., Carotenuto, V., Icolaro, N., et al. (2008). State and trait anxiety and depression in patients with primary brain tumors before and after surgery: 1-year longitudinal study. Journal of Neurosurgery, 108, 281-286.
14. Dantzer, R. (2006). Cytokines, sickness behavior and depression. Neurology Clinics, 24, 441-460.
15. Dantzer, R., & Kelley, K. W. (2007). Twenty years of research on cytokine-induced sickness behavior. Brain, Behavior, and Immunity, 21, 153-160.
16. Davies, E., Hall, S., & Clarke, C. (2003). Two year survival after malignant cerebral glioma: Patients and relative reports of handicap, psychiatric symptoms and rehabilitation. Disability and Rehabilitation, 25, 259-266.
17. Davis, S., Thomas, A., Perry, R., Oakley, A., Kalaria, R. N., & O'Brien, J. T. (2002). Glial fibrillary acidic protein in late life major depressive disorder: An immunocytochemical study. Journal of Neurology, Neurosurgery, and Psychiatry, 73, 556-560.
18. Dong, Y., & Benveniste, E. N. (2001). Immune function of astrocytes. Glia, 36, 180-190.
19. Fox, S., Shephard, T. J., & McCain, N. (1999). Neurological mechanisms in psychoneuroimmunology. Journal of Neuroscience Nursing, 31, 87-96.
20. Gathinji, M., McGirt, M. J., Attenello, F. J., Chaichana, K. L., Than, K., Olivi, A., et al. (2008). Association of preoperative depression and survival after resection of malignant brain astrocytoma. Surgical Neurology, 71, 299-303.
21. Giovagnoli, A. R. (1999). Quality of life in patients with stable disease after surgery, radiotherapy, and chemotherapy for malignant brain tumour. Journal of Neurology, Neurosurgery, and Psychiatry, 67, 358-363.
22. Giovagnoli, A. R., Silvani, A., Colombo, E., & Boiardi, A. (2005). Facets and determinants of quality of life in patients with recurrent high grade gliomas. Journal of Neurology, Neurosurgery, and Psychiatry, 76, 562-568.
23. Goodwin, J. S., Zhang, D. D., & Ostir, G. V. (2004). Effect of depression on diagnosis, treatment and survival of older women with breast cancer. Journal of the American Geriatrics Society, 52, 106-111.
24. Gross, A. F., Smith, F. A., & Stern, T. A. (2007). Is depression an appropriate response to having cancer? A discussion of diagnostic criteria and treatment decisions. Journal of Clinical Psychology, 9, 382-387.
25. Guo, Y., Musselman, D. L., Manatunga, A. K., Gilles, N., Lawson, K. C., Porter, M. R., et al. (2006). The diagnosis of major depression in patients with cancer: A comparative approach. Psychosomatics, 47, 376-384.
26. Hahn, C. A., Dunn, R. H., Logue, P. E., King, J. H., Edwards, C. L., & Halperin, E. C. (2003). Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primarymalignant brain tumors. International Journal of Radiation Oncology, Biology, Physics, 55, 992-999.
27. Hao, C., Parney, I. F., Roa, W. H., Turner, J., Petruk, K. C., & Ramsay, D. A. (2002). Cytokines and cytokine receptor mRNA expression in human glioblasomas: Evidence of Th1, Th2 and Th3 cytokine dysregulation. Acta Neuropathologica, 103, 171-178.
28. Hjerl, K., Andersen, E. W., Keiding, N., Mouridsen, H. T., Mortenson, P. B., & Jorgensen, T. (2003). Depression as a prognostic factor for breast cancer mortality. Psychosomatics, 44, 24-30.
29. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007). Cancer statistics, 2007. CA: A Cancer Journal for Clinicians, 57(1), 43-66.
30. Kelley, K. W., Bluthe, R. M., Dantzer, R., Zhou, J. H., Shen, W. H., Johnson, R. W., et al. (2003). Cytokine-induced sickness behaviors. Brain, Behavior, and Immunity, S1, S112-S118.
31. Kilbride, L., Smith, G., & Grant, R. (2007). The frequency and cause of anxiety and depression amongst patients with malignant brain tumours between surgery and radiotherapy. Journal of Neuro-Oncology, 84, 297-304.
32. Korzhevskii, D. E., Otellin, V. A., & Grigor'ev, I. P. (2005). Glial fibrillary acidic protein in astrocytes in the human neocortex. Neuroscience and Behavioral Physiology, 35, 789-792.
33. Kumar, R., Kamdar, D., Madden, L., Hills, C., Crooks, D., O'Brien, D., et al. (2006). Th1/Th2 cytokine imbalance in meningioma, anaplastic astrocytoma and glioblastoma multiforme patients. Oncology Reports, 15, 1513-1516.
34. Laping, N. J., Teter, B., Nichols, N. R., Rozorski, I., & Finch, L. E. (2008). Glial fibrillary acidic protein: Regulation by hormones, cytokines, and growth factors. Brain Pathology, 4, 259-275.
35. Liebrich, M., Guo, L. H., Schluesener, H. J., Schwab, J. M., Dietz, K., & Will, B. E. (2007). Expression of interleukin-16 by tumor-associated macrophages/activated microglia in high-grade astrocytic brain tumors. Archivum Immunologiae et Therapiae Experimentalis, 55, 41-47.
36. Lima, V. P., Geller, J., Bangsberg, D. R., Patterson, T. L., Daniel, M., Kerr, T., et al. (2007). The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS, 21, 1175-1183.
37. Lin, C. L., Lieu, A. S., Lee, K. S., Yang, Y. H. C., Kuo, T. H., Hung, M. H., et al. (2002). The conditional probabilities of survival in patients with anaplastic astrocytoma or glioblastoma multiforme. Surgical Neurology, 60, 402-406.
38. Litofsky, N. S., Farace, E., Anderson, F. Jr, Meyers, C. A., Huang, W., Laws, E. R. Jr, et al. (2004). Depression in patients with high-grade glioma: Results of the Glioma Outcomes Project. Neurosurgery, 54, 358-366.
39. Litofsky, N. S., & Resnick, A. G. (2009). The relationships between depression and brain tumors. Journal of Neuro-Oncology, 94, 153-161.
40. Lutterbach, J., Sauerbrei, W., & Guttenberg, R. (2003). Multivariate analysis of prognostic factors in patient with glioblastoma. Strahlentherapie und Onkologie, 1, 8-15.
41. Mainio, A., Hakko, H., Niemela, A., Koivukangas, J., & Rasanen, P. (2006). Gender difference in relation to depression and quality of life among patients with a primary brain tumor. European Psychiatry, 21, 194-199.
42. Mainio, A., Tuunanen, S., Hakko, H., Timonen, M., Niemela, A., Koivukangas, J., & Rasanen, P. (2005). Depression in relation to survival among neurosurgical patients with a primary brain tumor: A 5-year follow-up study. Neurosurgery, 56, 1234-1241.
43. Maletic, V., Robinson, M., Oakes, T., Iyengar, S., Ball, S. G., & Russell, J. (2007). Neurobiology of depression: An integrated view of key findings. International Journal of Clinical Practice, 61, 2030-2040.
44. McCain, N. L., Gray, D. P., Elswick, R. K., Robins, J. W., Tuck, I., Walter, J. M., et al. (2008). A randomized clinical trial of alternative stress management interventions in persons with HIV infection. Journal of Consulting and Clinical Psychology, 76, 431-441.
45. McCain, N. L., Gray, D. P., Walter, J. M., & Robins, J. (2005). Implementing a comprehensive approach to the study of health dynamics using the psychoneuroimmunology paradigm. Advances in Nursing Science, 28, 320-332.
46. McCain, N. L., Munjas, B. A., Munro, C. L., Elswick, R. K., Robins, J.W., Ferreira-Gonzales, A., et al. (2003). Effects of stress management on PNI-based outcomes in persons with HIV disease. Research in Nursing and Health, 26, 102-117.
47. McCarter, H., Furlong, W., Whitton, A. C., Feeny, D., DePauw, S., Willan, A. R., et al. (2006). Health status measurements at diagnosis as predictors of survival among adults with brain tumors. Journal of Clinical Oncology, 24, 3636-3643.
48. Miller, A. H., & Raison, C. L. (2008). Immune system contributions to the pathophysiology of depression. Focus, 6, 36-45.
49. Miller, D. B., & O'Callaghan, J. P. (2005). Depression, cytokines and glial function. Metabolism: Clinical and Experimental, 54, S33-S38.
50. Muguel-Hidalso, J. J., Baucom, C., Dilley, G., Overholser, J. C., Meltzer, H. Y., Stockmeier, C. A., et al. (2000). Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder. Biological Psychiatry, 48, 861-873.
51. Muller, N., & Schwarz, M. J. (2007). The immune-mediated alteration of serotonin and glutamate: Towards an integrated view of depression. Molecular Psychiatry, 12, 988-1000.
52. Myers, S. (2008). Proinflammatory cytokines and sickness behavior: Implications for depression and cancer-related symptoms. Oncology Nursing Forum, 35, 802-807.
53. Osaba, D., Brada, M., Prados, M. D., & Yung, W. K. A. (2000). Effects of disease burden on health-related quality of life in patients with malignant gliomas. Neurooncology, 2, 221-228.
54. Pelletier, G., Verhoef, M. J., Khatri, N., & Hagen, N. (2002). Quality of life in brain tumour patients: The relative contributions of depression, fatigue, emotional distress, and existential issues. Journal of Neuro-Oncology, 57, 41-49.
55. Pasquini, M., & Biondi, M. (2007). Depression in cancer patients: A critical review. Clinical Practice and Epidemiology in Mental Health, 3, 1-9.
56. Pringle, A. M., Taylor, R., & Whittle, I. R. (1999). Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery. British Journal of Neurosurgery, 13, 45-51.
57. Radeff Huang, J., Seasholtz, T. M., & Brown, J. H. (2005). Role of S1P signaling in TNF-alpha mediated astrocytoma cell proliferation. FASEB Journal, 19, A526-A527.
58. Raghavendra, V., Tanga, F. Y., & DeLeo, J. A. (2004). Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. European Journal of Neuroscience, 20, 467-473.
59. Reich, M. (2008). Depression and cancer: Recent data on clinical issues, research challenges and treatment approaches. Current Opinion in Oncology, 20, 353-359.
60. Samaras, V., Piperi, C., Korkolopoulou, P., Zisakis, A., Levidou, G., Themistocleous, M., et al. (2007). Application of the ELISPOT method for comparative analysis of interleukin (IL)-6 and IL-10 secretion in peripheral blood of patients with astroglial tumors. Molecular and Cellular Biochemistry, 304, 343-351.
61. Schneider, T., Sailer, M., Ansorge, S., Firsching, R., & Reinhold, D. (2006). Increased concentrations of transforming growth factor β1 and β2 in the plasma of patients with glioblastoma. Journal of Neuro-Oncology, 79, 61-65.
62. Starkweather, A. R., Witek-Janusek, L., & Mathews, H. L. (2005). Psychoneuroimmunology: An integrated research framework for neuroscience nurses. Journal of Neuroscience Nursing, 37, 56-61.
63. Vollmer-Conna, U., Fazou, C., Cameron, B., Li, H., Brennan, C., Luck, L., et al. (2004). Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behavior in humans. Psychological Medicine, 34, 1289-1297.
64. Wellisch, D. K., Kaleita, T. A., Freeman, D., Cloughesy, T., & Goldman, J. (2002). Predicting major depression in brain tumor patients. Psycho-Oncology, 11, 230-238.
65. Wichers, M., Maes, M. (2002). The psychoneuroimmunopathophysiology of cytokine induced depression in humans. International Journal of Neuropsychopharmacology, 5, 375-388.